Transcript Highlights:

• And a lot of people had opioid problems and addictions in this state.
• crisis. opioids.
• And a lot of people had opioid opioids.
• I'll say that with the opioid crisis.
• We saw it with opioids opioids opioids >> when<00:53:03.599> we<00:53:03.839> started

Keywords: 00:00:20 - Call to Order/Roll Call 00:02:00 - Update on Rural Health Transformation Program 00:29:20 - Discussion of 26RS HB 134 00:36:35 - Roll Call Vote on 26RS HB 134 00:37:41 - Consideration of Referred Administrative Regulations 01:09:44 - Adjournment, 958, all

Summary: The Health Services Committee met to receive an update from Cabinet for Health and Family Services Secretary Steven Stack on Kentucky’s Rural Health Transformation Grant. He explained that all 50 states applied and were awarded funding, and Kentucky received about $212.9 million over five years, with the first year treated as a nine-month period. He emphasized that the award is a cooperative agreement with CMS, is not Medicaid funding, cannot be used to supplant existing funds, and is limited to the five areas approved in Kentucky’s application. He also said the state must submit a revised budget before major spending begins, and that CMS could claw back money if performance metrics are not met. Secretary Stack outlined the five focus areas: maternal health, mental health, oral health, emergency medical services, and chronic disease prevention/management, especially obesity and diabetes. He described possible approaches such as expanding behavioral health crisis stabilization models like EMPath, using teledentistry and mobile services, strengthening EMS staffing and treat-in-place options, and building healthier nutrition and activity supports. He said the application was developed quickly with broad stakeholder input and that the state plans to work with universities, nonprofits, and other partners through procurement and other formal processes. He also noted the program will be overseen by the public health department, with Commissioner John Langfeld leading the effort. Committee members asked about the grant timeline, the split between formula and competitive funding, the role of certificate of need, and whether new laws or regulations would be needed. Stack said the state believes it can implement the approved projects under current law, though some broader policy issues such as certificate of need were not included because they would be risky to change within the grant timeline. Members also asked how stakeholders can submit ideas; Stack pointed them to the public website and contact email, saying additional partner information will be posted soon. The committee did not take any formal vote or action during this discussion.

Transcript Highlights:

• That's why you were against the bill because they could get opioids.
• I think you bring up a good point with the opioids.
• Robinson, don't we have limitations with opioid drugs now?
• Like top five is alcohol, nicotine, marijuana, opioids, and inhalants.
• And in terms of opioids, if it’s not opioids now, there’s going to be something else that comes up.

Summary: The committee first voluntarily deferred House Bills 460 and 561, then took up House Bill 1101 on workers’ compensation. The sponsor said the bill would define maximum medical improvement, adjust fraud provisions, shorten temporary total disability and supplemental earnings benefit periods, and revise vocational rehabilitation rules; an amendment removed proposed age-based termination language for benefits. Business groups including LABI supported the bill as a way to reduce Louisiana’s comparatively high indemnity costs and align the state with regional norms, while injured-worker advocates and attorneys strongly opposed it, arguing it would cut benefits, shift medical and disability decisions away from treating physicians and judges, broaden fraud too far, and potentially push costs onto public programs. After debate, the committee voted to report HB 1101 with amendments. House Bill 282 was voluntarily deferred. House Bill 293, which would add sexual orientation and gender identity to Louisiana employment discrimination protections, drew generally supportive testimony from the sponsor and supporters, with some members raising questions about religious exemptions and federal law. The committee ultimately voted against reporting HB 293 favorably. House Bill 390, providing unpaid leave protections for domestic abuse survivors at larger employers, was presented as a tool for survivors, but the committee split 6-6 on a motion to report it favorably; the tie resulted in the bill being voluntarily deferred. The committee then heard House Bill 456, which would expand workers’ compensation petition requirements and allow employers or payers broader access to file disputed claims and seek discovery. Supporters argued employers currently lack a practical way to obtain records and challenge claims without first cutting off benefits, while opponents said the bill would revive a rejected 2012 approach, increase litigation, and undermine the no-fault workers’ compensation bargain. The discussion centered on whether the bill would preserve benefits while allowing discovery or instead encourage more disputes and penalties. The transcript ends with testimony still underway on HB 456, with no final vote shown.

Transcript Highlights:

• provided by the state, which is an effective tool in both reducing New Mexico's high incidence of opioid
• provided by the state, which is an effective tool in both reducing New Mexico's high incidence of opioid
• you'll see is that the purple line represents total overdose deaths, but that blue line represents opioid
• Second, it blocks the euphoric effects of opioids. And third, it normalizes brain chemistry.
• , and additionally, it reduces the likelihood that they will overdose or die from opioids, as well as

Transcript Highlights:

• Kratom contains psychoactive compounds that have opioid and stimulant effects.
• It goes right to your opioid receptors. It gives you a euphoric high.
• opioids.
• opioids.
• Kratom binds to the opioid receptors in the body.

Bills: HB2205, HB2265, HB2413, HB2415, HB2418, HB2495, HB2589, HB2661, HB2720, HB2771, HB2833, HB2870

Keywords: criminal damage, trespassing, critical facilities, felony, Arizona Revised Statutes, court fees, public defender, criminal justice, legal aid, indigent defense, appeals, administrative assessments, sex offender, electronic monitoring, registration, public safety, youth protection, Kratom, narcotic drugs, regulation

Transcript Highlights:

• , but you can't testify that you're not against the bill if we exclude opioids.
• Robinson, don't we have limitations with opioid drugs now?
• Long-acting opioids, that was my job to check and the doctor's job to check.
• Like top five is alcohol, nicotine, marijuana, opioids, and inhalants.
• And in terms of opioids, if it’s not opioids now, there’s going to be something else that comes up.

Bills: HB282, HB293, HB390, HB456, HB460, HB561, HB819, HB1023, HB1047, HB1101

Keywords: employment discrimination, criminal history, rehabilitation, hiring process, human rights, gender identity, sexual orientation, workplace equality, labor rights, domestic abuse, unpaid leave, employee rights, workplace protection, mental health, survivor support, workers' compensation, employment benefits, claims process, fraud prevention, legal petition

Transcript Highlights:

• I lost a... ...I lost my son, my only child, to an opioid overdose.
• to apply more strict access controls that are now applied to opioids.
• medications cannot be more restrictive than access to opioid medications.
• It should not be easier for me to write a prescription for an opioid than it is to prescribe a non-opioid
• Delays in safer interventions increase the risk of opioid exposure.

Keywords: 995, all

Summary: The Joint Committee on Financial Services held a public hearing on a wide range of bills, with testimony first focused on H. 1315/S. 824, which would require insurance coverage for pain management options during IUD insertion. Representative Sabadosa, Planned Parenthood clinicians, and policy advocates said sedation can reduce fear and trauma, improve access to effective contraception, and should be reimbursed so providers can continue offering it. A Tufts OB-GYN resident also testified that pain control should be standard care for intrauterine procedures. No votes were taken during the hearing. The committee then heard extensive testimony on firefighter health bills, especially H. 1230/S. 690 requiring insurance coverage for cancer screenings for firefighters. Professional Fire Fighters of Massachusetts leaders, a Dana-Farber oncologist, and firefighters themselves described occupational exposure to carcinogens and personal stories of late-stage cancer detection, arguing that early screening can save lives and reduce long-term costs. Representative Crichton and Representative Howitt also spoke in support, and Representative Ayers testified for H. 4012, which would require neurological disorder screenings for firefighters. Committee members expressed support and sympathy, but no action was taken. The hearing also covered H. 3946/S. 756 on hearing aid coverage, with testimony from students, adults with hearing loss, disability advocates, and HLAA representatives describing the educational, social, and financial barriers caused by lack of coverage and urging broader insurance mandates. Later, Representative Donahue and Representative Vargas testified for H. 1337 to expand insurance coverage for opioid antagonists and related medications, including naloxone dispensed at discharge. The committee additionally heard testimony on H. 1134 to improve chronic pain care coordination and non-opioid access, and H. 4162 to improve ostomy supply coverage and access to certified ostomy care, with patients and clinicians describing denials, quantity limits, and non-medical switching. The transcript ends while testimony on H. 1315/S. 824 is still ongoing; no votes or formal committee actions are recorded in the excerpt.

Transcript Highlights:

• Vicki Ibarra, to talk about some of the impact on the data and impact of the opioid epidemic.
• This is EMS response statewide to opioid overdoses.
• I often go to the state opioid overdose dashboard or a county.
• Two-thirds, over two-thirds, 68 percent, were opioid-related. A third were not opioid-related.
• Involving opioid use and a child under three.

Summary: The Senate Human Services Committee held a work session on child welfare dependency, focusing on implementation of HB 1227 (Keeping Families Together) and SB 6109 (the fentanyl response bill), along with related data and system updates. DCYF first reviewed the dependency process, explaining intake, shelter care, fact-finding, disposition, and review hearings, and emphasized that removal standards are separate from service provision and that children may be in-home or out-of-home at different stages. DCYF said 1227 raised the removal threshold to imminent physical harm and strengthened kin placement, with nearly 60% of children now placed with relatives or suitable others. The department also said 6109 directs courts to give great weight to fentanyl’s lethality and added legal liaisons to support staff in court preparation. DCYF presented data showing that entries into out-of-home care declined after 1227 but rose again after 6109, returning close to pre-1227 levels. The agency also reported a sharp increase in reviewable critical incidents in 2022-2025, especially near-fatalities, which it linked to the opioid and fentanyl crisis, parental stress, and system complexity. DCYF said it has responded with statewide Safe Child Councils, staff consultations, hotspot monitoring, and additional training, and noted that some contracted services authorized under 6109 were not implemented because of fiscal constraints. Senators asked about where children are in the process, who participates in court, the timing of data releases, age breakdowns, and geographic hotspots. Advocates and lived-experience witnesses from LCYC and a family intervention clinic argued that 1227 has not prevented courts from removing children when necessary and said the law appropriately requires the state to show a causal link between home conditions and risk. They said 6109 appropriately highlights fentanyl’s danger, but stressed that the larger issue is lack of prevention and treatment resources, inconsistent county-by-county practice, and insufficient supports such as inpatient beds, family treatment, housing, transportation, and third-party safety plan participants. A parent ally described how early support, peer guidance, and kin placement helped her achieve recovery and stability after losing parental rights in an earlier case. The committee also heard an update on SB 6068 from the Administrative Office of the Courts and K Implementation and Evaluation. The report identified 15 dimensions of relational permanency and child well-being, found that some data already exist while other measures need development, and recommended a phased data collection plan, a restored data-sharing agreement between AOC and DCYF, and a standing cross-agency work group. AOC said its dependency data system lapsed when the prior agreement expired in June 2025 and needs to be rebuilt. The meeting also included a brief update on bridge housing for youth exiting inpatient treatment, with presenters saying two programs are now open, one in King County and one in Spokane, and a short introduction to juvenile rehabilitation capacity updates before the transcript ended.

Transcript Highlights:

• How much of the money from the opioid settlement fund was used for commercials of this nature?
• When you were head of DCF, you were on the Opioid Council. Is that true? Ma'am, please.
• Were you on the Opioid Settlement Council when you were head of DCF? I'm not sure of the words.
• The Opioid Abatement Council, maybe that's what it's called. Yeah.
• or any drug, really, but there was a focus on opioids.

Summary: The committee met to consider a large slate of appointments, with the main discussion centered on the confirmation of Chavon Harris as Secretary of the Agency for Health Care Administration (AHCA). Harris testified about her background in state service and outlined agency priorities including Medicaid financial accountability, transparency, managed care oversight, behavioral health redesign, rural health access, workforce recruitment, and use of technology and AI. Senators questioned her extensively about the Hope Florida/Medicaid settlement controversy, opioid settlement-funded advertising campaigns tied to marijuana prevention and the 2024 Amendment 3 election, public records compliance, abortion reporting and enforcement under the Heartbeat Protection Act, managed care denials, value-based purchasing, and Medicaid funding pressures. After debate, the committee voted to recommend her confirmation, with Senator Polsky voting no. The committee then considered Anna Ortega and Robert Payne for the Florida Public Service Commission. Ortega, a current PSC commissioner and former staff advisor, discussed utility regulation, data center load issues, ratepayer protections, transparency in PSC decisions, and lessons from other states. Payne, a former legislator and longtime utility co-op employee, emphasized his technical background and the need to balance utility returns with consumer affordability. Both nominees were confirmed by unanimous or near-unanimous votes and recommended favorably to the full Senate. Next, the committee heard from Jeffrey Aaron for reappointment to the Public Employees Relations Commission. Aaron described PERC’s role in public-sector labor disputes and said his work had been upheld in appellate courts without reversal. Senators questioned him about his law firm’s state contracts, his role as chairman of Attorney General James Uthmeier’s PAC, and his connection to the Hope Florida Foundation matter; he declined to discuss the pending investigation. Public testimony included opposition from Florida Voice for the Unborn. The committee nevertheless recommended his confirmation, with several no votes. Finally, the committee approved the remaining appointees on tabs 5 through 46 in a single vote, postponing Dr. John Littell and DCF Secretary Hatch, and then adjourned.

Transcript Highlights:

• /c> brain that receives the opioid um brain that receives the opioid um blocking<00:16:30.560> signals
• associated with typical opioid-like associated with typical opioid-like adverse<00:18:52.480>
• opioids or stimulants. opioids or stimulants.
• And so that were already on opioids.
• thing. uh where it acts on the opioid thing. uh where it acts on the opioid receptors<00:36:55.760

Bills: HB0103, HB0070, HB0091

Keywords: First Amendment, free speech, lawsuits, immunity, public participation, strategic lawsuits, foreign censorship, digital innovation, constitutional rights, Wyoming GRANITE Act, extraterritorial laws, civil actions, speech protection, legal jurisdiction, joint liability, artificial intelligence, social scoring, biometric data, privacy rights, government regulation

Transcript Highlights:

• That is through Brandeis, and I direct the opioid policy research collaborative there.
• I also co-direct the opioids and overdose work at Rhode Island Hospital and I'm at Brown.
• That is through Brandeis, and I direct the opioid policy research collaborative there.
• I also co-direct the opioids and overdose work at Rhode Island Hospital, and I'm at Brown.
• In a retrospective analysis of patients who were identified with opioid-related disorders and who were

Keywords: 995, all

Summary: The Special Commission on Xylazine convened its second meeting, approved the minutes from its June 23 meeting, and reviewed its timeline and working groups. The co-chairs said the commission’s final report is due to the House and Senate clerks by March 30, 2026, and outlined three working groups focused on regulation/oversight of xylazine, treatment and outreach for exposed patients, and education/training for first responders, clinicians, treatment providers, and people who use substances. Staff will schedule working group meetings, with group presentations planned for December 11, followed by commission meetings in February and March to review and finalize the draft report. Public comment centered on research and practical responses to xylazine contamination in the drug supply. Dr. Tracy Green of Brandeis reviewed recent studies showing severe xylazine-related wounds and amputations in Philadelphia, withdrawal symptoms, the value of wound identification tools, and the usefulness of drug checking in detecting xylazine even when users did not suspect it was present. She urged expanded low-barrier wound care, more access to medications for opioid use disorder, overdose prevention sites, housing, and trauma-informed care, while cautioning that stricter controls could push the market toward other dangerous alpha-2 substances. Commissioners asked about early wound identification, dilution/cutting strategies, supplier engagement, and how to reduce stigma and improve treatment access. Tia Johnson of Boston Medical Center and Boston Health Care for the Homeless testified that xylazine contamination still requires naloxone for overdose response, but sedation can last longer and may require low-dose naloxone, oxygen support, and low-threshold monitoring spaces. She emphasized that xylazine-associated wounds can heal with consistent care, but patients often lose access to services when sent to hospitals unnecessarily. Commissioners discussed reimbursement barriers, especially in MassHealth and behavioral health settings, and the need for wound care to be available within detox and treatment programs rather than requiring transfers. The meeting ended with agreement to continue working group planning and adjournment.

Transcript Highlights:

• Yeah, I've been thinking a lot about synthetic opioids, and uh there are a variety of synthetic opioids
• and uh there are variety of opioids and uh there are variety of synthetic<00:14:26.160> opioids
• that are out there in synthetic opioids that are out there in in<00:14:28.639> the<00:14:28.880
• I think this bill covers our bases for the variance in synthetic opioids that I was worried about.
• that I was variance in synthetic opioids that I was worried<00:19:53.360> about.

Bills: SF0009

Keywords: fentanyl, controlled substances, minors, drug distribution, enhanced penalties, 916, all

Transcript Highlights:

• Today we will hear testimony on 14 bills related to insurance, parity, and opioids.
• Today we will hear testimony on 14 bills related to insurance, parity, and opioids.
• I'm here to testify on Bill 2212, An Act to Patient Opioid Notification.
• This bill aims to address the increased prevalence of opioid abuse and overdose across the Commonwealth
• This bill aims to address the increased prevalence of opioid abuse and overdose across the risk.

Keywords: 995, all

Summary: The Joint Committee on Mental Health, Substance Use and Recovery held a public hearing on 14 bills focused on insurance, parity, opioids, behavioral health access, and mental health system reform. Chair Mindy Domb and Vice Chair Robyn Kennedy outlined hearing procedures and noted the committee would accept written testimony. The hearing featured testimony from legislators, providers, advocates, and behavioral health organizations, with most speakers urging favorable reports on the bills they addressed. A major topic was psychiatric collaborative care, including H. 222/S. 1390, which would raise reimbursement for collaborative care codes to at least Medicare levels and allow billing outside the MassHealth primary care subcapitation model. Supporters said the model improves access, outcomes, and cost savings by embedding behavioral health in primary care, and several witnesses described successful implementation in practices and schools. Committee members asked questions about how the model works, what specialties use it, barriers to adoption, and whether copays, deductibles, and subcapitation rules should be changed. Witnesses also supported related innovation legislation, including H. 2224, which would create a mental health innovation fund and support nontraditional trauma-healing approaches. Other bills discussed included H. 2212, which would require prescribers to discuss opioid and pain-medication risks, alternatives, and addiction/overdose concerns with patients or guardians; H. 2232 and H. 2233, which would address equitable payment and equitable access for behavioral health providers serving MassHealth patients; and S. 1406, which would add opioid maintenance treatment information to MassPAT and allow patient-authorized access to that information. Witnesses also strongly backed S. 1399, which would set targets to increase behavioral health spending within the overall health care cost benchmark, arguing that Massachusetts underinvests in behavioral health and that greater investment could reduce emergency, hospitalization, homelessness, and criminal justice costs. No votes were taken; the hearing concluded after testimony and committee questions.

Transcript Highlights:

• opioid treatment programs, and to provide for related matters.
• Louisiana has only opened one opioid treatment OTP since 2015 despite historic overdoses.
• That the people that are in need of opioid treatment have greater access to that treatment.
• So it's no opioids, opioid derivatives... That's not what we're asking for in this bill.
• So it's no opioids, opioid derivatives, no benzodiazepines, and then from there, MD oversight for any

Bills: HB946, HB1093, SB26, SB29, SB30, SB195, SB219, SB222, SB255, SB314, SCR2, SCR22

Keywords: healthcare transparency, hospital pricing, consumer protection, collection actions, fines, naturopathic medicine, Louisiana Board of Naturopathic Medicine, licensing, healthcare, prescriptive authority, natural therapies, opioid treatment, regulation, addiction recovery, state law, SB 29, Act 732, coroner, autopsy, child death

Summary: The committee first heard and favorably reported SB 255, which expands the educational qualifications for psychosocial rehabilitation services to include health sciences and therapeutic recreation degrees, and SB 314, which cleans up prior language on community psychiatric support and treatment services so a limited scope certified social worker license can still be issued even if the applicant is slightly late renewing. Members and witnesses said both bills were intended to improve access to behavioral health services, especially in rural areas, and there was no opposition on either measure. The committee then advanced SB 26, which repeals facility need review for opioid treatment programs to make it easier to open more OTPs in Louisiana, and SB 29, which requires child autopsy reports to include immunization records and access to the LINKS vaccine database. SB 29 drew some concern about whether singling out immunizations could imply causation, but the author and supporters said the bill is only about adding data and that the records would be part of broader medical information. Both bills were reported favorably. Members also reported favorably SB 30, as amended, to allow telehealth for obesity/weight-management treatment with synchronous interaction and other safeguards, though some providers warned the language should not unduly limit future board authority. SB 219 was approved to create an Office of Health and Nutrition within LDH, with testimony from the department, the Alzheimer’s Association, and Pennington Biomedical supporting the focus on nutrition, physical activity, and brain health. SB 222 was reported favorably with amendments to reduce duplicative behavioral health administrative requirements, streamline supervision rules, and expand telehealth for psychosocial rehabilitation. The committee also approved SB 195, the “Danny’s Dose” EMS bill, allowing EMS personnel to administer a patient’s own prescribed time-critical medication in emergencies; testimony from families with rare conditions described life-threatening delays under current rules. Finally, SCR 2 was adopted to update hospital construction standards to the most recent Facility Guidelines Institute edition, and SCR 22 was reported favorably to request a more detailed legislative auditor report on opioid settlement spending and outcomes. The committee then began hearing HB 1093 on naturopathic medicine, with the author proposing a licensing framework under the State Board of Medical Examiners and a large amendment set; members raised questions about scope, prescriptive authority, training, and whether the profession should have its own board, but no final action on the bill was taken in the portion provided.

Transcript Highlights:

• <00:14:35.720> to rightfully focused on using opioids to rightfully focused on using opioids
• <00:14:41.839> on opioids on opioids on campus<00:14:43.959> this<00:14:44.160> framework
• <00:15:06.360> Lac lucky enough not to receive opioids Lac lucky enough not to receive opioids
• Opioid overdose reversal medications such as naloxone are safe, effective, and can save a life.
• Opioid overdose reversal medications such as naloxone are safe, effective, and can save a life.

Keywords: 1187, senate, all

Transcript Highlights:

• facilities known as opioid treatment programs, or OTPs.
• It's not restricted to an opioid treatment program, which is a specialty facility.
• Those are medications specifically for opioid use disorders.
• Medications for opioid use disorder.
• Every individual suffering from opioid use disorder does not necessarily... for opioid use disorder,

Transcript Highlights:

• Naloxone is an effective agent in reversing opioid overdoses, but obviously it needs to be available
• In a study titled "Opioid overdose knowledge among adolescents and young adults," ...
• overdose—a preventable opioid overdose.
• overdose—a preventable opioid overdose.
• My research has focused extensively on school-based approaches to opioid overdose prevention.

Keywords: 995, all

Summary: The Joint Committee on Higher Education held its fourth public hearing, opening with remarks about the importance of protecting and expanding access to higher education amid federal disinvestment. The chairs also announced future informational hearings on the impact of federal cuts and on ASAP models. The hearing then focused on several bills, beginning with S. 951/H. 1462, An Act to Support College Students in Recovery, which would require recovery-focused housing on public campuses and expand naloxone access and overdose training. Senator Rausch, medical professionals, students, and advocates testified in support, emphasizing the prevalence of overdose risk among college students, the value of recovery housing, and the need for campus naloxone; committee members asked about implementation details and the existing state pilot program. Deb Schmill and Rep. Tarski gave especially personal testimony in favor of the bill, and the committee discussed broadening the naloxone language to opioid reversal agents. The committee also heard testimony on H. 1461, which would expand MassReconnect scholarships to practical nursing students at vocational and technical schools to help address the long-term care workforce shortage. Rep. Stanley argued that vocational schools graduate more practical nursing students than community colleges and serve many low-income students in areas without nearby community college programs. The committee then took up H. 1433, which would require public higher education institutions to accept IEPs and 504 plans as sufficient documentation for disability accommodations. Advocates from the National Center for Learning Disabilities described the high cost and burden of repeat testing, the lifelong nature of disabilities, and the need for more uniform access across campuses; committee members raised questions about documentation freshness, campus autonomy, and how to preserve the integrity of accommodations. Later, the committee heard S. 919/H. 1454 on modernizing the Community College Endowment Match Program so community colleges could receive state matching funds for current-use donations as well as endowments and capital gifts. Community college foundation leaders said the change would help fund immediate student needs such as food pantries, child care, emergency aid, and equipment. The hearing then moved to faculty-related bills: S. 933 on UMass faculty rights and tenure transparency, S. 930/H. 3948 on contingent faculty rights and career advancement, and S. 940/H. 1429 on an Adjunct Bill of Rights. Testimony from faculty and union representatives focused on low pay, lack of benefits, job insecurity, and the need for clearer pathways to full-time positions and fairer treatment for adjuncts who teach large shares of courses. No votes were taken during the hearing; the committee primarily received testimony and asked clarifying questions.

Transcript Highlights:

• opioid funds have been reverting the funds.
• And are they reverted to an opioid abatement fund or a trust?
• And are they reverted to an opioid abatement fund or a trust?
• of opioid settlement funds, Mr.
• Opioid. Oh, and feel free to come on up. Come on up, David, please.

Bills: HB1

Keywords: feed bill, legislative appropriations, legislative branch, New Mexico Legislature, general fund, legislative council service, legislative finance committee, legislative education study committee, house chief clerk, senate chief clerk, per diem, mileage, session expenses, interim committees, district staff, capitol complex, capital outlay data system, legislative processing system, redistricting, census redistricting

Transcript Highlights:

• And I want to be clear, the difference between opioids and what this bill does: opioids are prescribed
• Your question was about opioids are prescribed. So, opioids are prescribed, right?
• Your question was about opioids are prescribed. So, opioids are prescribed, right?
• if someone's on an opiate, an opioid if someone's on an opiate, an opioid that's<00:36:28.760>
• , they're impaired because of opioids, they're impaired because of opioids, which<00:59:07.440>

Keywords: Senate streaming session for Friday, March 6, 2026, 960, senate, all

Summary: The Senate opened with an invocation by Pastor Jermaine Turner, followed by welcoming remarks for visiting students and a quorum call confirming the chamber was in session. The body then moved through introductions and began considering bills and messages, including a supplemental budget message from the Governor that was journalized and referred to Budget and Taxation for incorporation into the FY27 budget. The chamber also handled several committee reports and amendments, with multiple measures ordered printed for third reading after no objections. Among the notable committee actions, the Senate adopted amendments and advanced Senate Bill 538 on Baltimore City raffles for organizations affiliated with professional baseball and football teams, Senate Bill 108 on water resources and wetlands enforcement, Senate Bill 328 on property tax credits for disabled or fallen public safety and judicial officers, Senate Bill 587 funding the Maryland Patient Safety Center Fund, Senate Bill 765 on property tax sales heir protection and tax credits, and Senate Bill 767 on property tax credits for commercial buildings rented to small businesses. The chamber also adopted favorable reports for Senate Bill 503 on the Growing Family Child Care Opportunities Program and Senate Bill 519 on delaying and studying the Earned Income Tax Credit Assistance Program. The Senate then took up third-reading votes on a series of bills, passing measures including Senate Bills 540, 544, 578, 581, 634, 638, 852, 897, 69, 177, 241, 323, 776, and 439. The final bill, Senate Bill 439 on employment discrimination related to fire and rescue public safety employees’ use of medical cannabis, prompted extended discussion about off-duty cannabis use, impairment, and the difference between prescribed opioids and medical cannabis recommendations. The bill sponsor and other senators debated whether cannabis can be prescribed, the role of physicians, and the lack of a measurable standard for impairment, but the transcript ends before a final vote on that bill is shown.

Transcript Highlights:

• opioid use disorder or OUD. opioid use disorder or OUD.
• am trained in the treatment of opioid am trained in the treatment of opioid use<00:04:01.680>
• Every shift I respond in real time to overdoses, opioid withdrawal, and cardiac arrest related to opioid
• > to<00:06:13.680> opioid<00:06:14.040> use cardiac arrest related to opioid use
• , patients can live very well on opioids, patients can live very well on opioids, do<00:15:52.240

Keywords: 1187, senate, all

Transcript Highlights:

• But yes, we would be looking at seeing if we could use some opioid settlement funds for that as well.
• definitive answers about what the local opioid... ...answers about what the local opioid money is going
• This is an area where we're currently funding services through opioid settlement dollars.
• We didn't fully fund it out of the opioid dollars, did we? We did not.
• Next, opioid funding, Mr... Budgeting, uh, next, so opioid funding. Mr.

Keywords: 924, joint, all